9 November 2026
IMI completes sale of Truflo Marine to Fairbanks Morse Defense
IMI plc (“IMI” or the “Group”), a global leader in fluid and motion control, announces that it has completed the sale of its Truflo Marine business to Fairbanks Morse Defense for an enterprise value of £225m1.
The sale was first announced on 24 November 2025 and completed on 6 November 2026.
Commenting, Roy Twite, Chief Executive Officer of IMI, said:
“The sale of Truflo Marine further aligns IMI to the three powerful megatrends that will underpin the delivery of sustainable growth - Energy, Automation and Healthcare. I would like to thank the Truflo Marine team for their significant contribution to the Group and wish them every success in the future.”
Enquiries to: | ||
Edward Hann | IMI | Tel: +44 (0)7977 354 810 |
Faeth Birch | FGS Global | Tel: +44 (0)7768 943 171 |
James Gray | FGS Global | Tel: +44 (0)7814 379 412 |
Note 1: The enterprise value of £225m includes an adjustment for £5m of lease liabilities treated as debt under IFRS. The equivalent enterprise value under US GAAP, where these lease liabilities are not treated as debt, is £220m.
Notes
IMI plc is a global leader in fluid and motion control. Its innovative solutions, built around valves and actuators, enable vital sectors to become safer, more productive and more energy efficient. IMI combines world-class applications engineering expertise with a continued focus on commercial excellence, market-led innovation and continuous improvement to solve its customers’ most acute engineering problems. IMI employs approximately 10,000 people, has manufacturing facilities in 18 countries and operates a global service network. IMI is a member of the FTSE 100 and is listed on the London Stock Exchange. Further information is available at www.imiplc.com.
IMI plc is registered in England No. 714275. Its legal entity identifier (‘LEI’) number is 2138002W9Q21PF751R30.
Brand materials can be found here.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
